Amneal PharmaceuticalsAMRX
那斯達克 · USD
13.24
-0.02
(-0.15%)
收盤 03/07 04:59 (UTC+8)
03/07 04:59 (UTC+8)
Amneal PharmaceuticalsAMRX
13.24
-0.02
(-0.15%)
財務數據
損益表
- 6.20
- 6.17
- 6.59
- 7.02
- 7.02
- 7.31
- 6.95
- 7.25
- 7.85
- 8.14
- 3.50
- -0.49
- 6.84
- 6.46
- 0.10
- 3.99
- -4.80
- 4.18
- 8.28
- 3.80
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 814,319 | 784,513 | 724,508 | 695,420 | 730,518 | 702,468 | 701,780 | 659,191 | 616,981 | 620,040 |
營業成本 | 517,129 | 510,539 | 438,255 | 439,529 | 467,645 | 432,910 | 451,833 | 421,131 | 427,154 | 387,509 |
營業毛利 | 297,190 | 273,974 | 286,253 | 255,891 | 262,873 | 269,558 | 249,947 | 238,060 | 189,827 | 232,531 |
營業費用 | 185,157 | 203,630 | 174,881 | - | 187,080 | - | 154,477 | 248,806 | 175,634 | 156,883 |
研發費用 | 34,819 | 63,352 | 47,964 | 40,040 | 54,265 | 61,097 | 36,054 | 39,298 | 46,086 | 41,375 |
推銷及管理費用 | 147,868 | 140,135 | 126,283 | 114,933 | 130,539 | 119,629 | 117,504 | 113,679 | 95,771 | 117,085 |
非經常性項目費用 | 2,470 | 143 | 634 | 571 | 2,276 | 23 | 919 | 95,829 | 33,777 | -1,577 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 114,503 | 70,344 | 111,372 | 100,347 | 75,793 | 88,809 | 95,470 | -10,746 | 14,193 | 75,648 |
其他收入及費用 | -561 | -12,753 | 5,440 | -5,922 | -29,450 | -7,875 | -9,346 | 927 | -38,106 | -1,782 |
利息費用 | 56,237 | 62,814 | 65,101 | 56,939 | 61,662 | 65,511 | 65,719 | 65,703 | 59,548 | 50,909 |
稅前純益 | 55,235 | -5,223 | 51,711 | 37,486 | -15,319 | 15,423 | 20,405 | -75,522 | -83,461 | 22,957 |
所得稅 | 5,662 | -23,355 | 16,101 | 12,868 | 5,423 | 3,666 | 3,618 | 6,156 | 9,883 | -2,076 |
稅後純益 | 35,076 | 2,369 | 22,417 | 12,195 | -31,081 | -156 | 5,994 | -91,643 | -98,649 | 9,682 |
基本每股稅後盈餘(元) | 0.11 | 0.01 | 0.07 | 0.04 | -0.10 | 0.00 | 0.02 | -0.30 | -0.40 | 0.06 |
稀釋每股稅後盈餘(元) | 0.11 | 0.00 | 0.07 | 0.04 | -0.10 | 0.00 | 0.02 | -0.30 | -0.57 | 0.06 |
基本平均股數(千股) | 314507.00 | 314168.00 | 313739.00 | 311054.00 | 309850.00 | 309647.00 | 309117.00 | 307279.00 | 243711.00 | 154219.00 |
稀釋平均股數(千股) | 328142.00 | 324754.00 | 322363.00 | 323961.00 | 309850.00 | 309647.00 | 318957.00 | 307279.00 | 243711.00 | 159691.00 |
還原基本每股稅後盈餘(元) | 0.11 | 0.01 | 0.07 | 0.04 | -0.10 | 0.00 | 0.02 | -0.30 | -0.40 | 0.06 |
還原稀釋每股稅後盈餘(元) | 0.11 | 0.00 | 0.07 | 0.04 | -0.10 | 0.00 | 0.02 | -0.30 | -0.57 | 0.06 |
還原基本平均股數(千股) | 314,507 | 314,168 | 313,739 | 311,054 | 309,850 | 309,647 | 309,117 | 307,279 | 243,711 | 154,219 |
還原稀釋平均股數(千股) | 328,142 | 324,754 | 322,363 | 323,961 | 309,850 | 309,647 | 318,957 | 307,279 | 243,711 | 159,691 |
EBITDA(千元) | 149,917 | 100,931 | 170,607 | 148,972 | 108,951 | 129,423 | 125,321 | 36,032 | 29,013 | 118,082 |